TGFB1 and lung carcinoma: demonstrated that GARP+ Tregs (Figure 1) were highly infiltrated in tumor tissues in the early stage of lung cancer and exerted immunosuppressive effects through the GARP‐TGF‐β pathway to inhibit Teffs.112